Multi-Omics Integration of Transcriptomics and Metabolomics with Machine Learning Uncovers Novel Risk Factors for Alzheimer’s disease
Multi-omics integration identified candidate biomarkers reflecting inflammatory signaling, mitochondrial dysfunction, and lipid metabolism reflecting inflammatory signaling, mitochondrial dysfunction, and lipid metabolism as well as influential genes and metabolites associated with cognition in Alzheimer's disease.